Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 46, Issue 2, February 2021, Pages 105-178
 
MONOGRAPHS
 
  
 Firibastat.
Brain aminopeptidase A inhibitor, Treatment of difficult-to-treat or resistant hypertension, Treatment of heart failure.
Gras, J.
Drugs Fut 2021, 46(2): 105
Summary | Full Text: PDF 
 
  
  
 Iberdomide.
Cereblon E3 ligase modulator (CELMoD), Treatment of systemic lupus erythematosus, Treatment of multiple myeloma.
Fuchs, O.
Drugs Fut 2021, 46(2): 115
Summary | Full Text: PDF 
 
  
  
 TNP-2092.
RNA polymerase (bacterial) inhibitor, DNA gyrase (bacterial) inhibitor, DNA topoisomerase IV (bacterial) inhibitor, Treatment of medical device-associated bacterial biofilm.
Takare, R., Dasgupta, A., Chopra, S.
Drugs Fut 2021, 46(2): 129
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the Move.
Torramade, E., Molas, G.
Drugs Fut 2021, 46(2): 143
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting (ACR Convergence 2020). Virtual – November 5-9, 2020.
Komlos, D.
Drugs Fut 2021, 46(2): 155
Summary | Full Text: PDF 
 
  
  
 Society for Immunotherapy of Cancer's (SITC) 35th Annual Meeting. Virtual – November 9-14, 2020.
Odland, J.
Drugs Fut 2021, 46(2): 163
Summary | Full Text: PDF 
 
  
  
 The Liver Meeting 2020. Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Virtual – November 13-16, 2020.
Puzzovio, S.
Drugs Fut 2021, 46(2): 169
Summary | Full Text: PDF 
 
  
  
 European Society of Medical Oncology (ESMO) Asia Congress 2020. Virtual – November 20-22, 2020.
Croasdell, G.
Drugs Fut 2021, 46(2): 175
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy